Current Value
$3.881 Year Return
Current Value
$3.881 Year Return
Yahoo
– Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonstrated 40% objective response rate – – The trial evaluated three doses of onvansertib in combination with paclitaxel, and objective responses were observed only at the highest dose of onvansertib – – The combination was well-tolerated and demonstrated a safe and manageable toxicity profile – SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF
Finnhub
Cardiff Oncology Inc: * CARDIFF ONCOLOGY ANNOUNCES POSITIVE DATA FROMINVESTIGATOR-INITIATED TRIAL OF ONVANSERTIB IN COMBINATION WITHPACLITAXEL IN METASTATIC TRIPLE-NEGATIVE BREAST...
Finnhub
Cardiff Oncology, Inc. announced positive data from an investigator-initiated Phase 1b clinical trial evaluating onvansertib in combination with paclitaxel in patients with metastatic triple-negative...
SeekingAlpha
Cardiff Oncology is entering a pivotal stage with a strong cash runway and compelling early data in first-line RAS-mutant mCRC. Click to read why CRDF is a Buy.
Yahoo
Cardiff Oncology ( NASDAQ:CRDF ) First Quarter 2025 Results Key Financial Results Net loss: US$13.4m (loss widened by...
Yahoo
- Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) - - Expanded intellectual property portfolio with second patent covering treatment of all bev-naïve patients, including RAS-mutated and RAS wild-type mCRC, across all lines of therapy - - Cash and investments of $79.9 million as of March 31, 2025, projected runway into Q1 2027 - SAN DIEGO, May 08, 2025 (GLOBE NEWSW
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
QURE | 42.61% | $888.02M | +207.20% | 0.00% |
BEAM | 39.42% | $1.80B | -31.35% | 0.00% |
TSE | 37.68% | $120.85M | +15.31% | 1.21% |
AUPH | 37.25% | $1.09B | +48.44% | 0.00% |
PUMP | 34.97% | $666.06M | -29.64% | 0.00% |
RICK | 34.61% | $373.53M | -5.72% | 0.65% |
NRIX | 34.49% | $962.86M | -23.45% | 0.00% |
EHTH | 34.14% | $132.83M | -12.40% | 0.00% |
ZYME | 34.06% | $904.86M | +37.61% | 0.00% |
PHR | 33.42% | $1.68B | +38.05% | 0.00% |
DMRC | 33.19% | $289.87M | -52.61% | 0.00% |
ABCL | 33.17% | $964.11M | -5.56% | 0.00% |
SYRE | 32.76% | $1.09B | -51.35% | 0.00% |
ONEW | 32.67% | $249.26M | -46.42% | 0.00% |
ACLX | 32.38% | $3.65B | +20.18% | 0.00% |
ALK | 32.36% | $5.97B | +18.41% | 0.00% |
IMNM | 32.32% | $825.75M | -40.69% | 0.00% |
LAB | 31.76% | $410.21M | -53.65% | 0.00% |
BNT | 31.70% | $11.90B | +41.42% | 0.00% |
SBGI | 31.65% | $932.96M | +9.83% | 7.58% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CON | <0.01% | $2.81B | -6.68% | 0.58% |
GFI | -0.01% | $21.79B | +53.72% | 2.21% |
NTZ | -0.02% | $43.62M | -22.35% | 0.00% |
CASI | 0.04% | $28.29M | -43.29% | 0.00% |
ASPS | 0.06% | $90.06M | -41.81% | 0.00% |
MNOV | -0.08% | $66.70M | +0.74% | 0.00% |
ERIE | 0.11% | $16.61B | +0.96% | 1.48% |
SBAC | -0.14% | $24.15B | +14.50% | 1.85% |
MSEX | -0.21% | $1.02B | +9.89% | 2.34% |
BE | -0.25% | $5.23B | +47.16% | 0.00% |
X | 0.27% | $12.11B | +43.61% | 0.37% |
TMUS | -0.28% | $262.22B | +32.88% | 1.44% |
PG | 0.29% | $380.07B | -1.86% | 2.51% |
UEIC | -0.32% | $94.69M | -37.21% | 0.00% |
DLNG | -0.33% | $133.34M | -5.93% | 3.98% |
TR | 0.37% | $2.45B | +20.21% | 1.09% |
GIS | -0.37% | $29.70B | -16.94% | 4.42% |
CABO | 0.39% | $756.82M | -62.63% | 6.62% |
PULM | -0.41% | $30.39M | +340.19% | 0.00% |
RPTX | -0.41% | $61.76M | -63.91% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MO | -11.98% | $100.92B | +30.61% | 6.82% |
AMT | -9.26% | $100.35B | +10.60% | 3.04% |
ACGL | -8.98% | $33.50B | -5.20% | 0.00% |
NEUE | -8.58% | $60.80M | +26.11% | 0.00% |
MCK | -8.28% | $89.80B | +22.74% | 0.39% |
MVO | -8.06% | $66.70M | -36.89% | 21.27% |
TEF | -7.96% | $29.51B | +15.71% | 5.96% |
COR | -7.92% | $55.56B | +24.55% | 0.74% |
NYT | -6.27% | $9.09B | +10.51% | 1.03% |
K | -6.14% | $28.31B | +38.89% | 2.82% |
ALL | -6.12% | $51.95B | +22.13% | 1.94% |
CI | -6.08% | $82.87B | -7.69% | 1.86% |
HUM | -5.96% | $27.97B | -34.24% | 1.52% |
NHTC | -5.92% | $53.54M | -33.38% | 17.28% |
HSY | -5.72% | $34.05B | -10.24% | 3.23% |
VHC | -5.60% | $37.77M | +135.71% | 0.00% |
HUSA | -5.51% | $8.56M | -56.67% | 0.00% |
PRT | -5.46% | $47.57M | +4.83% | 10.98% |
NOC | -5.41% | $70.30B | +14.35% | 1.72% |
CME | -5.40% | $97.17B | +37.77% | 3.95% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHYM | 0.02% | $324.00M | 0.35% |
TAXF | 0.10% | $490.73M | 0.29% |
SPTI | 0.12% | $8.60B | 0.03% |
IBTK | 0.13% | $429.15M | 0.07% |
TPMN | -0.14% | $30.69M | 0.65% |
SCHR | 0.15% | $10.64B | 0.03% |
TYA | 0.18% | $145.08M | 0.15% |
HYD | 0.21% | $3.28B | 0.32% |
LGOV | 0.23% | $690.80M | 0.67% |
TIPX | 0.28% | $1.65B | 0.15% |
TFI | -0.29% | $3.17B | 0.23% |
BSV | 0.29% | $38.06B | 0.03% |
SHY | 0.29% | $23.87B | 0.15% |
IBTM | 0.35% | $318.33M | 0.07% |
IBTF | -0.37% | $2.07B | 0.07% |
BILZ | -0.39% | $840.07M | 0.14% |
CLIP | -0.40% | $1.50B | 0.07% |
TFLO | 0.48% | $6.95B | 0.15% |
PZA | -0.52% | $2.81B | 0.28% |
IBTO | 0.62% | $340.82M | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 40.55% | $44.85M | 0.5% |
ARKG | 38.54% | $977.20M | 0.75% |
IWC | 36.97% | $815.56M | 0.6% |
XBI | 35.75% | $4.99B | 0.35% |
PTH | 34.44% | $105.01M | 0.6% |
KJUL | 34.43% | $120.33M | 0.79% |
IBB | 33.13% | $5.26B | 0.45% |
HEAL | 32.97% | $40.38M | 0.5% |
IWO | 32.73% | $11.49B | 0.24% |
PINK | 32.71% | $132.75M | 0.5% |
KJAN | 32.67% | $289.02M | 0.79% |
IWM | 32.45% | $63.71B | 0.19% |
XHE | 32.40% | $181.23M | 0.35% |
VTWO | 32.36% | $12.43B | 0.07% |
PBE | 32.19% | $228.06M | 0.58% |
IWMY | 31.89% | $109.69M | 1.02% |
ARKK | 31.60% | $6.23B | 0.75% |
GSSC | 31.46% | $557.11M | 0.2% |
CPRJ | 31.36% | $47.91M | 0.69% |
SCHA | 30.98% | $17.18B | 0.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -30.24% | $178.15M | 0.85% |
TAIL | -25.04% | $107.71M | 0.59% |
BTAL | -23.26% | $297.88M | 1.43% |
IVOL | -14.29% | $357.32M | 1.02% |
ULST | -11.72% | $667.10M | 0.2% |
XONE | -10.97% | $639.23M | 0.03% |
SGOV | -9.45% | $48.67B | 0.09% |
SHV | -8.60% | $20.33B | 0.15% |
FTSD | -8.55% | $228.22M | 0.25% |
SMMU | -8.10% | $862.96M | 0.35% |
STOT | -6.96% | $236.01M | 0.45% |
XHLF | -6.77% | $1.64B | 0.03% |
GBIL | -6.54% | $6.05B | 0.12% |
SPTS | -6.47% | $5.78B | 0.03% |
FXY | -6.46% | $855.96M | 0.4% |
UTWO | -5.84% | $374.45M | 0.15% |
FTSM | -5.14% | $6.44B | 0.45% |
XBIL | -5.13% | $787.59M | 0.15% |
CARY | -5.04% | $347.36M | 0.8% |
STPZ | -5.03% | $451.37M | 0.2% |